» Articles » PMID: 26858290

Introduction to the Analysis of Survival Data in the Presence of Competing Risks

Overview
Journal Circulation
Date 2016 Feb 10
PMID 26858290
Citations 907
Authors
Affiliations
Soon will be listed here.
Abstract

Competing risks occur frequently in the analysis of survival data. A competing risk is an event whose occurrence precludes the occurrence of the primary event of interest. In a study examining time to death attributable to cardiovascular causes, death attributable to noncardiovascular causes is a competing risk. When estimating the crude incidence of outcomes, analysts should use the cumulative incidence function, rather than the complement of the Kaplan-Meier survival function. The use of the Kaplan-Meier survival function results in estimates of incidence that are biased upward, regardless of whether the competing events are independent of one another. When fitting regression models in the presence of competing risks, researchers can choose from 2 different families of models: modeling the effect of covariates on the cause-specific hazard of the outcome or modeling the effect of covariates on the cumulative incidence function. The former allows one to estimate the effect of the covariates on the rate of occurrence of the outcome in those subjects who are currently event free. The latter allows one to estimate the effect of covariates on the absolute risk of the outcome over time. The former family of models may be better suited for addressing etiologic questions, whereas the latter model may be better suited for estimating a patient's clinical prognosis. We illustrate the application of these methods by examining cause-specific mortality in patients hospitalized with heart failure. Statistical software code in both R and SAS is provided.

Citing Articles

Kidney Transplant Fast Track and Likelihood of Waitlisting and Transplant: A Nonrandomized Clinical Trial.

Myaskovsky L, Leyva Y, Puttarajappa C, Kalaria A, Ng Y, Velez-Bermudez M JAMA Intern Med. 2025; .

PMID: 40063052 PMC: 11894542. DOI: 10.1001/jamainternmed.2025.0043.


Polygenic score integrating neurodegenerative and vascular risk informs dementia risk stratification.

DAoust T, Clocchiatti-Tuozzo S, Rivier C, Mishra A, Hachiya T, Grenier-Boley B Alzheimers Dement. 2025; 21(3):e70014.

PMID: 40042447 PMC: 11881617. DOI: 10.1002/alz.70014.


Identification of plasma proteomic markers underlying polygenic risk of type 2 diabetes and related comorbidities.

Loesch D, Garg M, Matelska D, Vitsios D, Jiang X, Ritchie S Nat Commun. 2025; 16(1):2124.

PMID: 40032831 PMC: 11876343. DOI: 10.1038/s41467-025-56695-z.


Comparison of seven models for the progression patterns of multiple chronic conditions in longitudinal studies.

Baneshi M, Mishra G, Dobson A BMJ Public Health. 2025; 2(2):e000963.

PMID: 40018552 PMC: 11816716. DOI: 10.1136/bmjph-2024-000963.


Cardiovascular disease risk in cancer survivors: a population-based cohort study from the UK Biobank, and meta-analysis of cohort studies.

Shu C, Mei Z, Yu B, Wang X, Wu H, Li C BMJ Public Health. 2025; 3(1):e001303.

PMID: 40017970 PMC: 11816107. DOI: 10.1136/bmjph-2024-001303.


References
1.
Latouche A, Allignol A, Beyersmann J, Labopin M, Fine J . A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions. J Clin Epidemiol. 2013; 66(6):648-53. DOI: 10.1016/j.jclinepi.2012.09.017. View

2.
Koller M, Raatz H, Steyerberg E, Wolbers M . Competing risks and the clinical community: irrelevance or ignorance?. Stat Med. 2011; 31(11-12):1089-97. PMC: 3575691. DOI: 10.1002/sim.4384. View

3.
Varadhan R, Weiss C, Segal J, Wu A, Scharfstein D, Boyd C . Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications. Med Care. 2010; 48(6 Suppl):S96-105. DOI: 10.1097/MLR.0b013e3181d99107. View

4.
Berry S, Ngo L, Samelson E, Kiel D . Competing risk of death: an important consideration in studies of older adults. J Am Geriatr Soc. 2010; 58(4):783-7. PMC: 2873048. DOI: 10.1111/j.1532-5415.2010.02767.x. View

5.
Tu J, Donovan L, Lee D, Wang J, Austin P, Alter D . Effectiveness of public report cards for improving the quality of cardiac care: the EFFECT study: a randomized trial. JAMA. 2009; 302(21):2330-7. DOI: 10.1001/jama.2009.1731. View